CDR3 Therapeutics
October 18, 2023
Franciscan B
Gene/Cell Therapy
The mission of CDR3 is to develop a curative stem cell gene immunotherapy, delivering chimeric antigen receptors (CARs) or T cell receptors (TCRs) to treat chronic viral infections and virus-associated cancers.
Speakers
Company Type
Privately Funded
Website
http://www.cdr3tx.com
CEO/Top Company Official
Otto Yang - Founder
Lead Product in Development
Stem-cell based TCR
Number Of Unlicensed Products
2
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)